Inactive Instrument

GelStat Corp. Stock Other OTC

Equities

GSAC

US3685331056

Pharmaceuticals

Sales 2021 0.01 Sales 2022 0 Capitalization 588K
Net income 2021 - Net income 2022 - EV / Sales 2021 858,660,496 x
Net Debt 2021 189K Net Debt 2022 361K EV / Sales 2022 407,113,588 x
P/E ratio 2021
-12 x
P/E ratio 2022
-0.74 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 90.48%
More Fundamentals * Assessed data
Dynamic Chart
GelStat Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
GelStat Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
GelStat Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
GelStat Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
GelStat Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
GelStat Corporation Auditor Raises 'Going Concern' Doubt CI
GelStat Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
GelStat Corp. Auditor Raises 'Going Concern' Doubt CI
GelStat Corporation Announces Management Changes CI
GelStat Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Revenue Guidance for 2015 CI
GelStat Corp. Announces Consolidated Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2014; Provides Revenue Guidance for 2015 CI
GelStat Corporation Reports Consolidated Earnings Results for the Third Quarter Ended September 30, 2014; Provides Revenue Guidance for the Fourth Quarter Ending December 31, 2014 CI
GelStat Corporation Reports Consolidated Revenue Results for the Third Quarter Ended September 30, 2014; Revises Revenue Guidance for the Fourth Quarter Ending December 31, 2014 CI
GelStat Corporation Signs Distribution Agreement with Next Distributors, LLC CI
GelStat Corp. Reports Revenue Results for the Second Quarter Ended June 30, 2014; Provides Revenue Guidance for the Third and Fourth Quarters of 2014 CI
More news
Managers TitleAgeSince
Chief Executive Officer - -
Members of the board TitleAgeSince
Director/Board Member 85 07-04-26
Chairman 66 08-03-31
Director/Board Member 81 11-11-03
More insiders
GelStat Corporation is engaged in research, development, marketing and branding of advanced technology operations. The Company's subsidiary, GSAC Engineering Corporation, is engaged in the development of technologies for clean energy and industrial security. The Company has acquired the intellectual property of Duos Technologies Group, Inc.
More about the company